Tina C Franklin1, Eric S Wohleb1, Yi Zhang1, Manoela Fogaça1, Brendan Hare1, Ronald S Duman2. 1. Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. 2. Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Electronic address: ronald.duman@yale.edu.
Abstract
BACKGROUND: Chronic stress-induced inflammatory responses occur in part via danger-associated molecular pattern (DAMP) molecules, such as high mobility group box 1 protein (HMGB1), but the receptor(s) underlying DAMP signaling have not been identified. METHODS: Microglia morphology and DAMP signaling in enriched rat hippocampal microglia were examined during the development and expression of chronic unpredictable stress (CUS)-induced behavioral deficits, including long-term, persistent changes after CUS. RESULTS: The results show that CUS promotes significant morphological changes and causes robust upregulation of HMGB1 messenger RNA in enriched hippocampal microglia, an effect that persists for up to 6 weeks after CUS exposure. This coincides with robust and persistent upregulation of receptor for advanced glycation end products (RAGE) messenger RNA, but not toll-like receptor 4 in hippocampal microglia. CUS also increased surface expression of RAGE protein on hippocampal microglia as determined by flow cytometry and returned to basal levels 5 weeks after CUS. Importantly, exposure to short-term stress was sufficient to increase RAGE surface expression as well as anhedonic behavior, reflecting a primed state that results from a persistent increase in RAGE messenger RNA expression. Further evidence for DAMP signaling in behavioral responses is provided by evidence that HMGB1 infusion into the hippocampus was sufficient to cause anhedonic behavior and by evidence that RAGE knockout mice were resilient to stress-induced anhedonia. CONCLUSIONS: Together, the results provide evidence of persistent microglial HMGB1-RAGE expression that increases vulnerability to depressive-like behaviors long after chronic stress exposure.
BACKGROUND: Chronic stress-induced inflammatory responses occur in part via danger-associated molecular pattern (DAMP) molecules, such as high mobility group box 1 protein (HMGB1), but the receptor(s) underlying DAMP signaling have not been identified. METHODS: Microglia morphology and DAMP signaling in enriched rat hippocampal microglia were examined during the development and expression of chronic unpredictable stress (CUS)-induced behavioral deficits, including long-term, persistent changes after CUS. RESULTS: The results show that CUS promotes significant morphological changes and causes robust upregulation of HMGB1 messenger RNA in enriched hippocampal microglia, an effect that persists for up to 6 weeks after CUS exposure. This coincides with robust and persistent upregulation of receptor for advanced glycation end products (RAGE) messenger RNA, but not toll-like receptor 4 in hippocampal microglia. CUS also increased surface expression of RAGE protein on hippocampal microglia as determined by flow cytometry and returned to basal levels 5 weeks after CUS. Importantly, exposure to short-term stress was sufficient to increase RAGE surface expression as well as anhedonic behavior, reflecting a primed state that results from a persistent increase in RAGE messenger RNA expression. Further evidence for DAMP signaling in behavioral responses is provided by evidence that HMGB1 infusion into the hippocampus was sufficient to cause anhedonic behavior and by evidence that RAGE knockout mice were resilient to stress-induced anhedonia. CONCLUSIONS: Together, the results provide evidence of persistent microglial HMGB1-RAGE expression that increases vulnerability to depressive-like behaviors long after chronic stress exposure.
Authors: Birgit Liliensiek; Markus A Weigand; Angelika Bierhaus; Werner Nicklas; Michael Kasper; Stefan Hofer; Jens Plachky; Herman-Josef Gröne; Florian C Kurschus; Ann Marie Schmidt; Shi Du Yan; Eike Martin; Erwin Schleicher; David M Stern; G ünterJ Hämmerling G; Peter P Nawroth; Bernd Arnold Journal: J Clin Invest Date: 2004-06 Impact factor: 14.808
Authors: Matthew G Frank; Michael V Baratta; David B Sprunger; Linda R Watkins; Steven F Maier Journal: Brain Behav Immun Date: 2006-05-02 Impact factor: 7.217
Authors: Carolina Demarchi Munhoz; Lucilia B Lepsch; Elisa Mitiko Kawamoto; Marília Brinati Malta; Larissa de Sá Lima; Maria Christina Werneck Avellar; Robert M Sapolsky; Cristoforo Scavone Journal: J Neurosci Date: 2006-04-05 Impact factor: 6.167
Authors: John D Johnson; Kevin A O'Connor; Terrence Deak; Matt Stark; Linda R Watkins; Steven F Maier Journal: Brain Behav Immun Date: 2002-08 Impact factor: 7.217
Authors: Thoralf M Wendt; Nozomu Tanji; Jiancheng Guo; Thomas R Kislinger; Wu Qu; Yan Lu; Loredana G Bucciarelli; Ling Ling Rong; Bernhard Moser; Glen S Markowitz; Gunther Stein; Angelika Bierhaus; Birgit Liliensiek; Bernd Arnold; Peter P Nawroth; David M Stern; Vivette D D'Agati; Ann Marie Schmidt Journal: Am J Pathol Date: 2003-04 Impact factor: 4.307
Authors: Christine T Ekdahl; Jan-Hendrik Claasen; Sara Bonde; Zaal Kokaia; Olle Lindvall Journal: Proc Natl Acad Sci U S A Date: 2003-10-27 Impact factor: 11.205
Authors: David J Clarke; Tariq W Chohan; Mustafa S Kassem; Kristie L Smith; Rose Chesworth; Tim Karl; Michael P Kuligowski; Sandra Y Fok; Maxwell R Bennett; Jonathon C Arnold Journal: Schizophr Bull Date: 2019-03-07 Impact factor: 9.306
Authors: Manoela V Fogaça; Kenichi Fukumoto; Tina Franklin; Rong-Jian Liu; Catharine H Duman; Ottavio V Vitolo; Ronald S Duman Journal: Neuropsychopharmacology Date: 2019-08-27 Impact factor: 7.853
Authors: Chantal M Sanchez; David J Titus; Nicole M Wilson; Julie E Freund; Coleen M Atkins Journal: J Neurotrauma Date: 2020-09-16 Impact factor: 5.269